Iqvia (IQV) net income: $1.4B
Iqvia reported a net income of $1.4B for the year ended Dec 31, 2025, down 0.9% from $1.4B a year earlier.
From Iqvia's filings with the SEC · Read the filing · IQV stock page
Iqvia net income by year
#291 of 3,748 US companies by net income · See the full ranking
| Year ended | Net income | Change |
|---|---|---|
| Dec 31, 2025 | $1.4B | -1% |
| Dec 31, 2024 | $1.4B | +1% |
| Dec 31, 2023 | $1.4B | +24% |
| Dec 31, 2022 | $1.1B | +13% |
| Dec 31, 2021 | $966M | – |
Net income of similar companies
Companies in the same industry as Iqvia, by SEC industry code, with the closest net income. Each name opens the same page for that company.
| Company | Net income, latest year | Year ended |
|---|---|---|
| Iqvia | $1.4B | Dec 31, 2025 |
| Incyte | $1.3B | Dec 31, 2025 |
| Medpace Holdings | $451M | Dec 31, 2025 |
| UL Solutions | $325M | Dec 31, 2025 |
| Icon | $229M | Dec 31, 2025 |
| Neogenomics | −$108M | Dec 31, 2025 |
| Charles River Laboratories International | −$144M | Dec 27, 2025 |
Questions and answers
What is Iqvia's net income?
Iqvia reported a net income of $1.4B for the year ended Dec 31, 2025, down 0.9% from $1.4B a year earlier.
Numbers as reported in Iqvia's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology